Notably, the anti-tumor activity observed in SN38-free CD19-CAR-M-Exosomes was limited, potentially due to the concentration of endogenous effector molecules within the exosomes being below the threshold required for lymphoma cell killing (18). This evidence concerns the gene CD19 and neoplasm.